Edwards Lifesciences Leverage Ratio Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 114.67  1.59  1.41%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Leverage Ratio of Edwards Lifesciences Corporation with missing and latest data points interpolated. Leverage Ratio is a measure of a firms financial leverage, calculated by dividing Average Assets by Average Equity. A component of DuPont return on equity analysis.
Leverage Ratio  10 Years Trend  
Increasing
Very volatile
 Leverage Ratio 
      Timeline 

Edwards Lifesciences Leverage Ratio Over Time

2015-12-31  1.59 
2016-12-31  1.59 
2017-12-31  1.74 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  1.59
Geometric Mean  1.58
Coefficient Of Variation  8.99
Mean Deviation  0.1
Median  1.59
Standard Deviation  0.14
Sample Variance  0.020388
Range  0.49
R Value  0.047079
Mean Square Error  0.022377
R Squared  0.002216
Significance  0.88
Slope  0.001864
Total Sum of Squares  0.22

Currently Trending

AJRD   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 34.4
I   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 6.4
CBAY   
 NCM 
Purchased over 90 shares of
few hours ago ago
Traded for 8.14